𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical study on treatment of liver fibrosis of chronic hepatitis B patients with Ginkgo leaf

✍ Scribed by Yun He; Feng-yi Yuan; Jian-bin Wang; Shu-lian Shao; Hong-bo Yuan; Xiao-xin Huang

Publisher
Chinese Association of Traditional and Western Medicine
Year
2002
Tongue
English
Weight
741 KB
Volume
8
Category
Article
ISSN
1672-0415

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Severe lactic acidosis during treatment
Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function
✍ Christian M. Lange; JΓΆrg Bojunga; Wolf Peter Hofmann; Katrin Wunder; Ulrike Mihm πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 221 KB πŸ‘ 1 views

Entecavir is a potent nucleoside inhibitor of the hepatitis B virus (HBV) polymerase with a high antiviral efficacy and a high genetic barrier to viral resistance. After approval in 2006, knowledge on the side effect profile in patients with advanced liver disease and impaired liver function is stil

High prevalence of significant liver fib
High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe
✍ Thomas GΓΆbel; Andreas Erhardt; Mathias Herwig; Christopher Poremba; Stephan Erns πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 1 views

## Abstract The indication for antiviral treatment of patients with chronic hepatitis B is based on serum HBV DNA levels, transaminases, and histological grade and stage. The relation of liver fibrosis and inflammation to ALT activity in chronic hepatitis B infection was investigated in a non‐endem